CONTACT | Print Page | Sign In | Join
News & Press: Scientific Advancements

Scripps Research comes together to help combat the global pandemic

Saturday, March 21, 2020   (0 Comments)
Share |

Scripps Research | Special Edition

COVID-19 Coronavirus Disease


March 21, 2020

Painting by Scripps Research professor David S. Goodsell, PhD*

Scripps Research scientists tackle COVID-19 coronavirus pandemic from many angles

Scientists all across the institute are working tirelessly to combat the current COVID-19 pandemic. Our researchers are pursuing multiple lines of investigation aimed at understanding and helping to mitigate the impact of the novel coronavirus that has spread across the globe.

With support from the Bill & Melinda Gates Foundation, as well as laboratories around the world, teams are tracing how the virus originated and spreads, exploring how it invades the body and how the immune system responds, and working to develop potential vaccines and medicines against the virus. Read more

The COVID-19 coronavirus pandemic has a natural origin, scientists say

A team of scientists led by Scripps Research used genomics to uncover the answer to a key question in the COVID-19 pandemic: How did the new virus come to be?

The novel coronavirus, known as SARS-CoV-2, causes the illness that has sickened more than 265,500 and killed at least 11,000 since it emerged last year in the city of Wuhan, China. The team analyzed public genome sequence data from SARS-CoV-2 and related viruses, and concluded that the new strain came as a result of natural selection. They found no evidence that the virus was made in a laboratory or otherwise engineered.

“By comparing the available genome sequence data for known coronavirus strains, we can firmly determine that SARS-CoV-2 originated through natural processes,” said Kristian Andersen, PhD, an associate professor of immunology and microbiology at Scripps Research and corresponding author on the paper. Read more


Coronavirus FAQs

What is a coronavirus? Where did this outbreak come from? And how can we help stem the spread? As the situation surrounding the current pandemic intensifies, we answer a collection of some of the most frequently asked questions about COVID-19. Read more


Calibr, the drug development division of Scripps Research, is leveraging its powerful ReFRAME drug repurposing collection to find anti-viral drugs for those who have been exposed to the novel coronavirus. To view all videos click here.


About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 6,700 establishments and research organizations in the BioPharma, MedTech, HealthIT & BioAg that collectively employ nearly 94,000 Floridians.